1 study found for:    11560997 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients
Condition: Melanoma
Interventions: Drug: Daclizumab;   Biological: Dendritic cells

Indicates status has not been verified in more than two years